Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 41 of 41 entries
View as:

Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic Uncertainty

Phase: N/A Priority: Normal
NCT ID: NCT00129675 Org: User:
Start: 02/28/03 End: 05/31/09 Due: 05/31/10

Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513

Phase: N/A Priority: Normal
NCT ID: NCT01000870 Org: User:
Start: 10/31/09 End: 09/30/10 Due: 09/30/11

Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00870519 Org: User:
Start: 01/31/09 End: 12/31/10 Due: 12/31/11

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00132626 Org: User:
Start: 09/30/92 End: 08/31/05 Due: 08/31/06

Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00427674 Org: User:
Start: 01/31/07 End: 10/31/09 Due: 10/31/10

A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00117819 Org: User:
Start: 03/31/01 End: 01/31/13 Due: 01/31/14

Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression

Phase: N/A Priority: Normal
NCT ID: NCT00134784 Org: User:
Start: 04/30/00 End: 05/31/07 Due: 05/31/08

Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01462708 Org: User:
Start: 05/31/11 End: 05/31/13 Due: 05/31/14

A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00117195 Org: User:
Start: 05/31/03 End: 01/31/12 Due: 01/31/13

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00096720 Org: User:
Start: 02/29/04 End: 05/31/07 Due: 05/31/08

Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00470925 Org: User:
Start: 05/31/07 End: 02/29/08 Due: 02/28/09

Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC

Phase: N/A Priority: Normal
NCT ID: NCT01268020 Org: User:
Start: 12/31/10 End: 10/31/12 Due: 10/31/13

Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00970229 Org: User:
Start: 07/31/09 End: 05/31/15 Due: 05/31/16

Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a

Phase: N/A Priority: Normal
NCT ID: NCT01461083 Org: User:
Start: 09/30/11 End: 05/31/14 Due: 05/31/15

Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00970333 Org: User:
Start: 08/31/09 End: 10/31/10 Due: 10/31/11

Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease

Phase: N/A Priority: Normal
NCT ID: NCT00397696 Org: User:
Start: 11/30/06 End: 01/31/12 Due: 01/31/13